Search - tctmd.com

Displaying 821 - 840 of 1426

Sort: Relevancy | Date

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Qi Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Jian Liu

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Zening Jin

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) from: EXCEL and NOBLE

Presenter: Yves R. Louvard, John D. Puskas, Davide Capodanno

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Presenter: Robert A. Guyton, Martin B. Leon, Marc Ruel

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Presenter: Robert A. Guyton, Martin B. Leon, David E. Kandzari

October 31, 2016

Presentation TCT 2016

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Niels R. Holm

October 31, 2016

Presentation TCT 2016

SYNTAX Stratified NOBLE Results

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Ian Menown

October 31, 2016

Presentation TCT 2016

NOBLE Left main Bifurcation Stent Techniques

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Mitchell Lindsay

October 31, 2016

Presentation TCT 2016

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Presenter: Seung-Jung Park, Alan C. Yeung, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Diabetes in the NOBLE Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Olli A. Kajander

October 31, 2016

Presentation TCT 2016

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn

October 31, 2016

Presentation TCT 2016

NOBLE Top Line Results Revisited

Presenter: Evald H. Christiansen, Per Hostrup Nielsen

October 31, 2016

Presentation TCT 2016

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Presenter: Graham A. Cassel, Narek Zakaryan

October 31, 2016

Advertisement

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

Highlights (and my Interpretations) from: EXCEL and NOBLE

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

SYNTAX Stratified NOBLE Results

NOBLE Left main Bifurcation Stent Techniques

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Diabetes in the NOBLE Trial

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

NOBLE Top Line Results Revisited

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content